Updated safety and clinical activity of durvalumab monotherapy in previously treated patients with stage IIIB/IV NSCLC P. Sadjadian,D. Jaeger, U. Keilholz,J. von Pawel, M-O. Grimm, M. BoegemannONCOLOGY RESEARCH AND TREATMENT（2018）引用 6|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
